Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.84
-0.07 (-1.18%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
AI-designed multi-antivirals are advancing toward clinical trials, targeting large unmet needs in respiratory infections with rapid, cost-effective development and broad-spectrum efficacy. Strategic partnerships and non-dilutive funding support growth, with significant milestones expected in the next 12–24 months.